Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.

Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J, Johansson JO, Tang C, Chui HC, Harrington MG, Michaelson DM, Yassine HN.

J Neurosci. 2019 Nov 27;39(48):9611-9622. doi: 10.1523/JNEUROSCI.1400-19.2019. Epub 2019 Oct 22.

PMID:
31641056
2.

ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.

Kegulian NC, Ramms B, Horton S, Trenchevska O, Nedelkov D, Graham MJ, Lee RG, Esko JD, Yassine HN, Gordts PLSM.

Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2145-2156. doi: 10.1161/ATVBAHA.119.312723. Epub 2019 Aug 8.

PMID:
31390883
3.

Sex-Related Differences in Brain Volumes and Cerebral Blood Flow Among Overweight and Obese Adults With Type 2 Diabetes: Exploratory Analyses from the Action for Health in Diabetes Brain Magnetic Resonance Imaging Study.

Espeland MA, Hayden KM, Lockhart SN, Yassine HN, Hoscheidt S, Yasar S, Luchsinger JA, Neiberg RH, Brinton RD, Carmichael O; Action for Health in Diabetes Brain Magnetic Resonance Imaging (Look AHEAD Brain) Research Group.

J Gerontol A Biol Sci Med Sci. 2019 Apr 8. pii: glz090. doi: 10.1093/gerona/glz090. [Epub ahead of print]

PMID:
30997482
4.

Low-Density Lipoprotein Particle Size Subfractions and Cerebral Amyloidosis.

Lee S, Parekh T, King SM, Reed B, Chui HC, Krauss RM, Yassine HN.

J Alzheimers Dis. 2019;68(3):983-990. doi: 10.3233/JAD-181252.

PMID:
30883362
5.

Targeting prodromal Alzheimer's disease: too late for prevention?

Yassine HN.

Lancet Neurol. 2017 Dec;16(12):946-947. doi: 10.1016/S1474-4422(17)30372-1. Epub 2017 Oct 30. No abstract available.

6.

Lessons from the Multidomain Alzheimer Preventive Trial.

Yassine HN, Schneider LS.

Lancet Neurol. 2017 Aug;16(8):585-586. doi: 10.1016/S1474-4422(17)30227-2. Epub 2017 Jul 11. No abstract available.

7.

Ex vivo instability of glycated albumin: A role for autoxidative glycation.

Jeffs JW, Ferdosi S, Yassine HN, Borges CR.

Arch Biochem Biophys. 2017 Sep 1;629:36-42. doi: 10.1016/j.abb.2017.07.004. Epub 2017 Jul 13.

8.

Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions.

Mendoza S, Trenchevska O, King SM, Nelson RW, Nedelkov D, Krauss RM, Yassine HN.

J Clin Lipidol. 2017 Jan - Feb;11(1):224-233.e2. doi: 10.1016/j.jacl.2016.12.009. Epub 2016 Dec 28.

9.

DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA.

Yassine HN, Croteau E, Rawat V, Hibbeln JR, Rapoport SI, Cunnane SC, Umhau JC.

Alzheimers Res Ther. 2017 Mar 23;9(1):23. doi: 10.1186/s13195-017-0250-1.

10.

Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.

Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC.

JAMA Neurol. 2017 Mar 1;74(3):339-347. doi: 10.1001/jamaneurol.2016.4899. Review.

11.

Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.

Azizkhanian I, Trenchevska O, Bashawri Y, Hu J, Koska J, Reaven PD, Nelson RW, Nedelkov D, Yassine HN.

J Clin Lipidol. 2016 Jul-Aug;10(4):808-815. doi: 10.1016/j.jacl.2016.03.001. Epub 2016 Mar 8.

12.

Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.

Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust WJ, Chui HC.

JAMA Neurol. 2016 Oct 1;73(10):1208-1216. doi: 10.1001/jamaneurol.2016.1924.

PMID:
27532692
13.

The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.

Yassine HN, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, Aisen PS, Chui HC, Schneider LS.

Alzheimers Res Ther. 2016 Jun 30;8:25. doi: 10.1186/s13195-016-0194-x.

14.

Development of quantitative mass spectrometric immunoassay for serum amyloid A.

Trenchevska O, Yassine HN, Borges CR, Nelson RW, Nedelkov D.

Biomarkers. 2016 Dec;21(8):743-751. doi: 10.1080/1354750X.2016.1201533. Epub 2016 Jul 22.

15.

The association of plasma cystatin C proteoforms with diabetic chronic kidney disease.

Yassine HN, Trenchevska O, Dong Z, Bashawri Y, Koska J, Reaven PD, Nelson RW, Nedelkov D.

Proteome Sci. 2016 Mar 25;14:7. doi: 10.1186/s12953-016-0096-7. eCollection 2016.

16.

ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.

Yassine HN, Feng Q, Chiang J, Petrosspour LM, Fonteh AN, Chui HC, Harrington MG.

J Am Heart Assoc. 2016 Feb 12;5(2). pii: e002886. doi: 10.1161/JAHA.115.002886.

17.

The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides.

Yassine HN, Trenchevska O, Ramrakhiani A, Parekh A, Koska J, Walker RW, Billheimer D, Reaven PD, Yen FT, Nelson RW, Goran MI, Nedelkov D.

PLoS One. 2015 Dec 3;10(12):e0144138. doi: 10.1371/journal.pone.0144138. eCollection 2015.

18.

Site specific modification of the human plasma proteome by methylglyoxal.

Kimzey MJ, Kinsky OR, Yassine HN, Tsaprailis G, Stump CS, Monks TJ, Lau SS.

Toxicol Appl Pharmacol. 2015 Dec 1;289(2):155-62. doi: 10.1016/j.taap.2015.09.029. Epub 2015 Oct 3.

19.

The Application of Multiple Reaction Monitoring to Assess Apo A-I Methionine Oxidations in Diabetes and Cardiovascular Disease.

Yassine HN, Jackson AM, Reaven PD, Nedelkov D, Nelson RW, Lau SS, Borchers CH.

Transl Proteom. 2014 Dec 1;4-5:18-24.

20.

Serum amyloid a truncations in type 2 diabetes mellitus.

Yassine HN, Trenchevska O, He H, Borges CR, Nedelkov D, Mack W, Kono N, Koska J, Reaven PD, Nelson RW.

PLoS One. 2015 Jan 21;10(1):e0115320. doi: 10.1371/journal.pone.0115320. eCollection 2015.

21.

Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.

Yassine HN, Belopolskaya A, Schall C, Stump CS, Lau SS, Reaven PD.

Metabolism. 2014 May;63(5):727-34. doi: 10.1016/j.metabol.2014.03.001. Epub 2014 Mar 5.

22.

The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins.

Yassine HN, Jackson AM, Borges CR, Billheimer D, Koh H, Smith D, Reaven P, Lau SS, Borchers CH.

Lipids Health Dis. 2014 Jan 8;13:8. doi: 10.1186/1476-511X-13-8.

23.

The use of metformin is associated with decreased lumbar radiculopathy pain.

Taylor A, Westveld AH, Szkudlinska M, Guruguri P, Annabi E, Patwardhan A, Price TJ, Yassine HN.

J Pain Res. 2013 Dec 9;6:755-63. doi: 10.2147/JPR.S52205. eCollection 2013. Erratum in: J Pain Res. 2014;7:89.

24.
25.

Effect of glucose or fat challenge on aspirin resistance in diabetes.

Yassine HN, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF.

Int J Endocrinol. 2010;2010:820876. doi: 10.1155/2010/820876. Epub 2011 Jan 26.

26.

New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism.

Kimzey MJ, Yassine HN, Riepel BM, Tsaprailis G, Monks TJ, Lau SS.

Chem Biol Interact. 2011 Jun 30;192(1-2):122-8. doi: 10.1016/j.cbi.2010.09.032. Epub 2010 Oct 8.

27.

Clinical determinants of aspirin resistance in diabetes.

Yassine HN, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF.

Diabetes Res Clin Pract. 2010 Oct;90(1):e19-21. doi: 10.1016/j.diabres.2010.07.008. Epub 2010 Aug 16.

28.

Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial.

Yassine HN, Marchetti CM, Krishnan RK, Vrobel TR, Gonzalez F, Kirwan JP.

J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):90-5. doi: 10.1093/gerona/gln032. Epub 2009 Jan 20.

Supplemental Content

Loading ...
Support Center